PROLOCOR

prolocor-logo

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.

#SimilarOrganizations #People #Financial #Event #Website #More

PROLOCOR

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical

Founded:
2020-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.prolocor.com

Total Employee:
1+

Status:
Active

Email Addresses:
info@prolocor.com

Total Funding:
6.9 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Global Site Tag Google Analytics 4 Cloudflare JS CDN JS


Similar Organizations

billiontoone-logo

BillionToOne

BillionToOne is a precision diagnostics company focused on genetic testing for disease detection.

cardurion-pharmaceuticals-logo

Cardurion Pharmaceuticals

Cardurion is a Boston-based cardiovascular biotechnology company

catalym-logo

Catalym

Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.

clarapath-logo

Clarapath

We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.

heartbeat-health-logo

Heartbeat Health

Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management.

natera-logo

Natera

Natera specializes in cell-free DNA testing to elevate the science and utility of prenatal testing.

octagos-health-logo

Octagos Health

Octagos Health is a digital health company focused on remote monitoring of cardiac devices.

quest-diagnostics-logo

Quest Diagnostics

Quest Diagnostics is a clinical laboratory that offers diagnostic testing, services, and information.

senti-biosciences-logo

Senti Biosciences

Senti Biosciences is a developer of a programmable biology platform for cancer therapies.

valneva-logo

Valneva

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Current Employees Featured

david-schneider_image

David Schneider
David Schneider Co-Founder & CSO @ Prolocor
Co-Founder & CSO

peter-m-dibattiste_image

Peter M. DiBattiste
Peter M. DiBattiste CEO, Co-Founder & President @ Prolocor
CEO, Co-Founder & President

not_available_image

Raymond Russo
Raymond Russo Chief Commercial Officer @ Prolocor
Chief Commercial Officer
2024-03-01

Founder


david-schneider_image

David Schneider

peter-m-dibattiste_image

Peter M. DiBattiste

Investors List

labcorp-venture-fund_image

LabCorp Venture Fund

LabCorp Venture Fund investment in Convertible Note - Prolocor

green-park-golf-ventures_image

Green Park & Golf Ventures

Green Park & Golf Ventures investment in Convertible Note - Prolocor

green-park-golf-ventures_image

Green Park & Golf Ventures

Green Park & Golf Ventures investment in Seed Round - Prolocor

laboratory-corporation-of-america_image

LabCorp

LabCorp investment in Seed Round - Prolocor

small-business-innovation-research_image

Small Business Innovation Research

Small Business Innovation Research investment in Grant - Prolocor

Key Employee Changes

Date New article
2024-03-11 Prolocor Announces Appointment of Raymond Russo as Chief Commercial Officer

Official Site Inspections

http://www.prolocor.com Semrush global rank: 8.95 M Semrush visits lastest month: 445

  • Host name: vps68528.inmotionhosting.com
  • IP address: 70.39.251.123
  • Location: Los Angeles United States
  • Latitude: 33.956
  • Longitude: -118.3887
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90045

Loading ...

More informations about "Prolocor"

Prolocor

Feb 20, 2025 Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use of PLATELET FCɣRIIA (PFCG) As Key Tool In Individualizing Dual Antiplatelet Therapy (DAPT) read more. October 21, 2024. Prolocor …See details»

Who We Are - Prolocor

David co-founded Prolocor and has served as the company’s CSO since 2020. David is a Professor of Medicine at the University of Vermont and has been at the University for the past …See details»

Prolocor - Crunchbase Company Profile & Funding

Prolocor may be growing as it has recently secured $1.7 million in bridge funding, which suggests an influx of capital that can be used for further development, research, or expansion of …See details»

Prolocor - Org Chart, Teams, Culture & Jobs - The Org

View Prolocor's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

PROLOCOR INC. Company Profile | Shelburne, VT - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for PROLOCOR INC. of Shelburne, VT. Get the latest business insights from Dun & Bradstreet.See details»

Prolocor - Funding, Financials, Valuation & Investors - Crunchbase

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. ... How much …See details»

PROLOCOR INC. Company Profile | Philadelphia, PA | Competitors ...

Find company research, competitor information, contact details & financial data for PROLOCOR INC. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»

Prolocor - Updates, News, Events, Signals & Triggers - Crunchbase

Aug 16, 2022 Organization. Prolocor . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. ... Funding Round • …See details»

Prolocor - Contacts, Employees, Board Members, Advisors & Alumni

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»

Prolocor - VentureRadar

At Prolocor, we are developing a novel test based on FcyRIIa, a protein expressed on the surface of platelets, the blood cells that are involved in thrombosis or clot formation4-5. Most …See details»

Prolocor

Info@prolocor.com. A novel diagnostic test to quantify FcyRIIa on the surface of platelets. Let's scratch the surface. In the United States, atherosclerotic cardiovascular disease is a leading …See details»

Prolocor 2025 Company Profile: Valuation, Funding & Investors

Prolocor has raised $4.9M. Who are Prolocor’s investors? Green Park & Golf Ventures , Labcorp Venture Fund , Laboratory Corporation of America , National Heart, Lung, and Blood Institute, …See details»

What We Do - Prolocor

Info@prolocor.com. What We Do. problem. CV disease is the leading cause of death and disability around the world 1. USA. 20000000. adults have coronary artery disease (CAD) 2. …See details»

Prolocor - Overview, News & Similar companies | ZoomInfo.com

Feb 29, 2024 Who is Prolocor. Prolocor, Inc is a precision diagnostics company headquartered in Philadelphia, PA and Burlington, VT. The company's innovative precision diagnosti c test is being developed to guide cardiovascular treatment decisions, effectively matching the intensity of antithrombotic therapy with the risk of thrombotic events. Founded by a team that deeply …See details»

Prolocor | Seed

Prolocor’s mission is to develop a precision tool that will revolutionize treatment by identifying patients at high and low risk for heart attack, stroke, and death. Platelets contribute to …See details»

Prolocor to Present New Clinical Evidence at ACC 25 Supporting …

Feb 20, 2025 Prolocor looks forward to participating in this important event. Please stop by booth FH21. ABOUT PROLOCOR, INC. Founded by a team that deeply understands …See details»

Prolocor - Products, Competitors, Financials, Employees, …

Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use... Feb 21, 2025. PHILADELPHIA, PA / ACCESS Newswire / February 20, 2025 / Prolocor, Inc., a healthcare startup developing the innovative diagnostic Prolocor pFCG™ test that identifies patients at higher and lower risk of thrombotic events (heart attack, stroke, and death), announced today the …See details»

How We Do It | Prolocor

Info@prolocor.com. How We Do It. our approach. Our approach is guided by our vision to advance patient care, by empowering the healthcare community with effective precision …See details»

A Brief History of Prolocor – CanvasBusinessModel.com - CBM

Oct 2, 2024 Founding and Origins of Prolocor. Prolocor was founded in 2010 by a team of experienced biotechnologists with a passion for developing innovative solutions in the field of cardiovascular diseases. The company was established with the vision of revolutionizing the way cardiovascular diseases are diagnosed and treated, with a focus on improving patient …See details»

Mission, Vision & Core Values of Prolocor – …

Oct 2, 2024 Prolocor's commitment to innovation and excellence in diagnostic testing is reflected in its mission, vision, and core values. The company's dedication to advancing healthcare …See details»

linkstock.net © 2022. All rights reserved